Diseases, Conditions, Syndromes

Prurigo nodularis more likely in African-Americans

(HealthDay)—African-American patients are more likely to have prurigo nodularis (PN), which is associated with systemic, cardiovascular, and psychiatric comorbidities, according to a study recently published in the Journal ...

Diseases, Conditions, Syndromes

WHO targets for chronic hepatitis B will be cost-effective

(HealthDay)—Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs.

Diseases, Conditions, Syndromes

Canada updates guidelines for hepatitis C virus infection

(HealthDay)—A guideline published in the June 4 issue of CMAJ, the journal of the Canadian Medical Association, provides updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus ...

Diseases, Conditions, Syndromes

Availability of generic antivirals for hepatitis B increasing

(HealthDay)—Availability of generic antivirals for treating chronic hepatitis B virus (HBV) is increasing, according to research published in the July 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity ...

Diseases, Conditions, Syndromes

Cost-effective universal screening for hepatitis C in France

An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, Ph.D., a research associate at IAME (Infection, Antimicrobials, Modeling, Evolution) ...

Diseases, Conditions, Syndromes

Sofosbuvir improves renal safety in patients with chronic hep C

(HealthDay)—Sofosbuvir-based treatment appears to guarantee renal safety for patients with chronic hepatitis C virus over one year of follow-up, according to a study published online May 7 in the Journal of Clinical Pharmacy ...

page 10 from 35